This is a Validated Antibody Database (VAD) review about human MYH13, based on 6 published articles (read how Labome selects the articles), using MYH13 antibody in all methods. It is aimed to help Labome visitors find the most suited MYH13 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
MYH13 synonym: MyHC-IIL; MyHC-eo

Santa Cruz Biotechnology
mouse monoclonal (B-5)
  • western blot; mouse; 1:2000; loading ...; fig 1c
Santa Cruz Biotechnology MYH13 antibody (Santa Cruz, sc-376157) was used in western blot on mouse samples at 1:2000 (fig 1c). Aging (Albany NY) (2020) ncbi
mouse monoclonal (B-5)
  • immunocytochemistry; human; 1:100; loading ...
Santa Cruz Biotechnology MYH13 antibody (Santa Cruz Biotechnology, sc-376157) was used in immunocytochemistry on human samples at 1:100. elife (2019) ncbi
mouse monoclonal (B-5)
  • immunocytochemistry; mouse; 1:2000; loading ...; fig 2c
  • western blot; mouse; 1:2000; loading ...; fig 2b
Santa Cruz Biotechnology MYH13 antibody (Santa Cruz, sc-376157) was used in immunocytochemistry on mouse samples at 1:2000 (fig 2c) and in western blot on mouse samples at 1:2000 (fig 2b). Gene (2017) ncbi
mouse monoclonal (B-5)
  • western blot; mouse; 1:1000; fig 4d
Santa Cruz Biotechnology MYH13 antibody (SantaCruz, sc-376157) was used in western blot on mouse samples at 1:1000 (fig 4d). Sci Rep (2017) ncbi
mouse monoclonal (B-5)
  • immunocytochemistry; mouse; 1:100; loading ...; fig 5b ii
Santa Cruz Biotechnology MYH13 antibody (Santa Cruz, sc-376157) was used in immunocytochemistry on mouse samples at 1:100 (fig 5b ii). Biomater Res (2017) ncbi
mouse monoclonal (B-5)
  • western blot; mouse; loading ...; fig 1c
Santa Cruz Biotechnology MYH13 antibody (Santa Cruz, sc-376157) was used in western blot on mouse samples (fig 1c). Oncotarget (2016) ncbi
Articles Reviewed
  1. Chung L, Liu S, Huang S, Salter D, Lee H, Hsu Y. High phosphate induces skeletal muscle atrophy and suppresses myogenic differentiation by increasing oxidative stress and activating Nrf2 signaling. Aging (Albany NY). 2020;12:21446-21468 pubmed publisher
  2. Herdy J, Schäfer S, Kim Y, Ansari Z, Zangwill D, Ku M, et al. Chemical modulation of transcriptionally enriched signaling pathways to optimize the conversion of fibroblasts into neurons. elife. 2019;8: pubmed publisher
  3. Wang X, Zeng R, Xu H, Xu Z, Zuo B. The nuclear protein-coding gene ANKRD23 negatively regulates myoblast differentiation. Gene. 2017;629:68-75 pubmed publisher
  4. Guo Y, Wang J, Zhu M, Zeng R, Xu Z, Li G, et al. Identification of MyoD-Responsive Transcripts Reveals a Novel Long Non-coding RNA (lncRNA-AK143003) that Negatively Regulates Myoblast Differentiation. Sci Rep. 2017;7:2828 pubmed publisher
  5. Cha S, Lee H, Koh W. Study of myoblast differentiation using multi-dimensional scaffolds consisting of nano and micropatterns. Biomater Res. 2017;21:1 pubmed publisher
  6. Ramazzotti G, Billi A, Manzoli L, Mazzetti C, Ruggeri A, Erneux C, et al. IPMK and β-catenin mediate PLC-β1-dependent signaling in myogenic differentiation. Oncotarget. 2016;7:84118-84127 pubmed publisher